- ASSISTANT PROFESSOR | Pediatrics, Gastroenterology
- Pediatric Gastroenterology and Hepatology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
New York, NY 10029
New York, NY 10029
David Dunkin, MD is an Assistant Professor of Pediatrics in the Division of Pediatric Gastroenterology. Dr. Dunkin obtained his undergraduate degree from Cornell University and received his MD from the Sackler School of Medicine. He completed his Pediatric residency at Yale Children’s Hospital followed by a fellowship in Pediatric Gastroenterology at the Mount Sinai Medical Center. In addition to his clinical practice, his current research explores the development of food allergies and the use of Chinese herbal medicines for the treatment of IBD. His research has been funded by the National Institutes of Health (NIH). Dr. Dunkin’s clinical practice includes all areas of pediatric gastroenterology with a special interest in inflammatory bowel disease.
- Crohn's Disease
- Inflammatory Bowel Disease
- Milk Allergy
- Rectal Bleeding
- Ulcerative Colitis
MD, Sackler School of Medicine
Yale-New Haven Children's Hospital
Fellowship, Pediatric Gastroenterology
Mount Sinai Hospital
Clinical Study of Chinese Herbal Medicine for Inflammatory Bowel Disease
The purpose of this study is to see if inflammatory cytokines (markers or chemicals in the blood/tissue that are associated with active inflammatory bowel disease) will be effected by the addition of Chinese herbal medicines that are added to cultures of blood cells or tissue spe...
Gordon J, Ramaswami A, Beuttler M, Jossen J, Pittman N, Lai J, Dunkin D, Benkov K, Dubinsky M. EBV Status and Thiopurine Use in Pediatric IBD. Journal of pediatric gastroenterology and nutrition 2015 Dec;.
Liu C, Yang N, Song Y, Wang L, Zi J, Zhang S, Dunkin D, Busse P, Weir D, Tversky J, Miller RL, Goldfarb J, Zhan J, Li XM. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. International immunopharmacology 2015 May;.
Liu C, Dunkin D, Lai J, Song Y, Ceballos C, Benkov K, Li XM. Anti-inflammatory Effects of Ganoderma lucidum Triterpenoid in Human Crohn's Disease Associated with Downregulation of NF-κB Signaling. Inflammatory bowel diseases 2015 May;.
Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen KM, Maleki SJ, Sampson HA, Berin MC. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. The Journal of clinical investigation 2014 Oct;.
Ceballos C, Bao R, Dunkin D, Song Y, Li XM, Benkov K. Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates 2014 Jul; 37(4): 265-71.
Mathern DR, Laitman LE, Hovhannisyan Z, Dunkin D, Farsio S, Malik TJ, Roda G, Chitre A, Iuga AC, Yeretssian G, Berin MC, Dahan S. Mouse and human Notch-1 regulate mucosal immune responses. Mucosal immunology 2014 Jul; 7(4): 995-1005.
Srivastava KD, Dunkin D, Liu C, Yang N, Miller RL, Sampson HA, Li XM. Effect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2014 Apr; 112(4): 339-47.
Song Y, Dunkin D, Dahan S, Iuga A, Ceballos C, Hoffstadter-Thal K, Yang N, Benkov K, Mayer L, Li XM. Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD. Inflammatory bowel diseases 2014 Jan; 20(1): 144-53.
Dunkin D, Berin MC, Mayer L. Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner. The Journal of allergy and clinical immunology 2011 Dec; 128(6): 1251-1258.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Dunkin did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.